SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-025900
Filing Date
2023-09-14
Accepted
2023-09-14 16:06:52
Documents
1
Period of Report
2023-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3914
  Complete submission text file 0001437749-23-025900.txt   5498
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address
Jacob Jeffrey E. (Reporting) CIK: 0001934189 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 231255187